| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcf9d7dac3a69acf14ea77810bb74b25 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 |
| filingDate |
2017-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f255748935b0bc70cc4e09df8efa9a1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1778cd4fbb81d8f7f6b2446617ab95ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a218a8da365fa84f0b3ba5b3bb55c00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f27fc47b68bc5bdf3dc5f86eea8319ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d84d10f3ab0abbc2e94e5506d608605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6201769f0c9c13898e6baf08a59673d2 |
| publicationDate |
2021-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3560928-B1 |
| titleOfInvention |
Fused imidazole compound having indoleamine 2,3-dioxygenase inhibitory activity |
| priorityDate |
2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |